Watch ARTL. Know when insiders buy.
One email the day a filing lands. Free.
ARTL
ARTELO BIOSCIENCES, INC.
6.04
−0.18 −2.89%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $55.5MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$12.7MNET CASH —52W 5.95 – 159.03SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$2.5M | −$2.4M | — | -0.89 | −$5M | — | — | Aug 12 |
| Q1 2026 · Mar 31 | — | — | — | −$2.7M | −$3M | — | -4.00 | −$1.2M | — | — | May 14 |
| Q4 2025 · Dec 31derived | — | — | — | −$2.8M | −$4.2M | — | -0.04 | −$2.9M | — | — | Feb 24 |
| Q3 2025 · Sep 30 | — | — | — | −$3.1M | −$3.1M | — | -3.97 | −$3.5M | — | — | Nov 12 |
| Q2 2025 · Jun 30 | — | — | — | −$3.1M | −$3.2M | — | -16.86 | −$514K | — | — | Aug 12 |
| Q1 2025 · Mar 31 | — | — | — | −$2.4M | −$2.4M | — | -12.55 | −$1.6M | — | — | May 14 |
| Q4 2024 · Dec 31derived | — | — | — | −$3.8M | −$3.8M | — | -7.02 | −$2.6M | — | — | Feb 24 |
| Q3 2024 · Sep 30 | — | — | — | −$1.2M | −$1.1M | — | -2.10 | −$778K | — | — | Nov 12 |
| Q2 2024 · Jun 30 | — | — | — | −$2.5M | −$2.4M | — | -4.52 | −$2.1M | — | — | Nov 12 |
| Q1 2024 · Mar 31 | — | — | — | −$2.6M | −$2.5M | — | -0.78 | −$2.9M | — | — | Nov 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$3.2M | −$3.1M | — | -0.99 | −$2.6M | — | — | Mar 3 |
| Q3 2023 · Sep 30 | — | — | — | −$2.6M | −$2.4M | — | -0.83 | −$1.8M | — | — | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$11.4M | −$12.9M | — | -12.52 | −$8.5M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$10.1M | −$9.8M | — | -18.30 | −$8.3M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$9.9M | −$9.3M | — | -3.14 | −$8.2M | — | — | — | — |
| FY2022 · to Dec 31 | — | — | −$10.3M | −$10.1M | — | — | −$8M | — | — | — | — |
| FY2021 · to Dec 31 | — | — | −$9.4M | −$9.4M | — | — | — | — | — | — | — |
| FY2021 · to Aug 31 | — | — | −$7.4M | −$7.4M | — | -0.40 | −$6.1M | — | — | — | — |
Every number comes from ARTELO BIOSCIENCES, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.